Lynne Chou O’Keefe
Founder & Managing Partner, Define Ventures
Lynne Chou O’Keefe is the Founder and Managing Partner of Define Ventures, one of the largest firms focused on early-stage health tech companies. With $800 million in assets under management. Define Ventures is a high-conviction team with a proven track record in scaling category-defining companies driving $23 billion in exit value including Hims & Hers (HIMS); Livongo (LVGO); and Evolent (EVH).
Prior to Define, Lynne’s experience includes both healthcare operating, investing, and finance roles. Previously, she was a Senior Partner at Kleiner Perkins focused on digital health and connected devices early stage investing. Before joining Kleiner Perkins, Lynne worked at Abbott Vascular and Guidant in multiple roles launching over ten product families in the US and internationally. Lynne was responsible for building the global commercial strategy and therapy development as well as playing a key role in the clinical, reimbursement, and operational strategy for these therapies. Earlier in her career, Lynne worked at Apax Partners with a focus on software venture capital investing. In addition, Lynne worked at Goldman Sachs in the Mergers and Acquisitions group and worked on multiple multi-billion dollar acquisitions and sell side transactions in various industries.
Lynne has been named WSJ’s Women in Venture Capital to Watch, FierceHealthcare’s Women of Influence, and Rock Health’s Top 50 ICON honoree. Lynne earned a Bachelor of Science degree in Industrial Engineering from Stanford University and an M.B.A. from Harvard Business School.